Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
In this report, the global Nuclear Medicine/Radiopharmaceutic market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Nuclear Medicine/Radiopharmaceutic in these regions, from 2014 to 2025 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Nuclear Medicine/Radiopharmaceutic market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
China Isotope Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Cardinal Health
Mallinckrodt
GE Healthcare
Lantheus Medical Imaging
Bayer Healthcare
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
Nordion
Advanced Accelerator Applications
Iba Molecular Imaging
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Diagnostic
Therapeutic
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Nuclear Medicine/Radiopharmaceutic for each application, including
Oncology
Thyroid
Cardiology
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Nuclear Medicine/Radiopharmaceutic Market Research Report 2019
1 Nuclear Medicine/Radiopharmaceutic Market Overview
1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceutic
1.2 Nuclear Medicine/Radiopharmaceutic Segment by Type (Product Category)
1.2.1 Global Nuclear Medicine/Radiopharmaceutic Production and CAGR (%) Comparison by Type (Product Category)(2014-2024)
1.2.2 Global Nuclear Medicine/Radiopharmaceutic Production Market Share by Type (Product Category) in 2018
1.2.3 Diagnostic
1.2.4 Therapeutic
1.3 Global Nuclear Medicine/Radiopharmaceutic Segment by Application
1.3.1 Nuclear Medicine/Radiopharmaceutic Consumption (Sales) Comparison by Application (2014-2024)
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.3.5 Others
1.4 Global Nuclear Medicine/Radiopharmaceutic Market by Region (2014-2024)
1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size (Value) and CAGR (%) Comparison by Region (2014-2024)
1.4.2 North America Status and Prospect (2014-2024)
1.4.3 Europe Status and Prospect (2014-2024)
1.4.4 China Status and Prospect (2014-2024)
1.4.5 Japan Status and Prospect (2014-2024)
1.4.6 Southeast Asia Status and Prospect (2014-2024)
1.4.7 India Status and Prospect (2014-2024)
1.5 Global Market Size (Value) of Nuclear Medicine/Radiopharmaceutic (2014-2024)
1.5.1 Global Nuclear Medicine/Radiopharmaceutic Revenue Status and Outlook (2014-2024)
1.5.2 Global Nuclear Medicine/Radiopharmaceutic Capacity, Production Status and Outlook (2014-2024)
2 Global Nuclear Medicine/Radiopharmaceutic Market Competition by Manufacturers
2.1 Global Nuclear Medicine/Radiopharmaceutic Capacity, Production and Share by Manufacturers (2014-2019)
2.1.1 Global Nuclear Medicine/Radiopharmaceutic Capacity and Share by Manufacturers (2014-2019)
2.1.2 Global Nuclear Medicine/Radiopharmaceutic Production and Share by Manufacturers (2014-2019)
2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Share by Manufacturers (2014-2019)
2.3 Global Nuclear Medicine/Radiopharmaceutic Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Nuclear Medicine/Radiopharmaceutic Manufacturing Base Distribution, Sales Area and Product Type
2.5 Nuclear Medicine/Radiopharmaceutic Market Competitive Situation and Trends
2.5.1 Nuclear Medicine/Radiopharmaceutic Market Concentration Rate
2.5.2 Nuclear Medicine/Radiopharmaceutic Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue (Value) by Region (2014-2019)
3.1 Global Nuclear Medicine/Radiopharmaceutic Capacity and Market Share by Region (2014-2019)
3.2 Global Nuclear Medicine/Radiopharmaceutic Production and Market Share by Region (2014-2019)
3.3 Global Nuclear Medicine/Radiopharmaceutic Revenue (Value) and Market Share by Region (2014-2019)
3.4 Global Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.5 North America Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.6 Europe Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.7 China Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.8 Japan Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.9 Southeast Asia Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
3.10 India Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Nuclear Medicine/Radiopharmaceutic Supply (Production), Consumption, Export, Import by Region (2014-2019)
4.1 Global Nuclear Medicine/Radiopharmaceutic Consumption by Region (2014-2019)
4.2 North America Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export, Import (2014-2019)
4.3 Europe Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export, Import (2014-2019)
4.4 China Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export, Import (2014-2019)
4.5 Japan Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export, Import (2014-2019)
4.6 Southeast Asia Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export, Import (2014-2019)
4.7 India Nuclear Medicine/Radiopharmaceutic Production, Consumption, Export, Import (2014-2019)
5 Global Nuclear Medicine/Radiopharmaceutic Production, Revenue (Value), Price Trend by Type
5.1 Global Nuclear Medicine/Radiopharmaceutic Production and Market Share by Type (2014-2019)
5.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type (2014-2019)
5.3 Global Nuclear Medicine/Radiopharmaceutic Price by Type (2014-2019)
5.4 Global Nuclear Medicine/Radiopharmaceutic Production Growth by Type (2014-2019)
6 Global Nuclear Medicine/Radiopharmaceutic Market Analysis by Application
6.1 Global Nuclear Medicine/Radiopharmaceutic Consumption and Market Share by Application (2014-2019)
6.2 Global Nuclear Medicine/Radiopharmaceutic Consumption Growth Rate by Application (2014-2019)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Nuclear Medicine/Radiopharmaceutic Manufacturers Profiles/Analysis
7.1 China Isotope Radiation
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 China Isotope Radiation Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business/Business Overview
7.2 Dongcheng
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Dongcheng Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business/Business Overview
7.3 Jaco
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Jaco Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business/Business Overview
7.4 Ciaeriar
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Ciaeriar Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business/Business Overview
7.5 Advanced Molecular-imaging Solution
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business/Business Overview
7.6 Shanghai Atom Kexing
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business/Business Overview
7.7 Cardinal Health
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Cardinal Health Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business/Business Overview
7.8 Mallinckrodt
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business/Business Overview
7.9 GE Healthcare
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business/Business Overview
7.10 Lantheus Medical Imaging
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business/Business Overview
7.11 Bayer Healthcare
7.12 Bracco Imaging
7.13 Eczacibasi-Monrol Nuclear Products
7.14 Nordion
7.15 Advanced Accelerator Applications
7.16 Iba Molecular Imaging
8 Nuclear Medicine/Radiopharmaceutic Manufacturing Cost Analysis
8.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Manufacturers in 2015
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Nuclear Medicine/Radiopharmaceutic Market Forecast (2019-2024)
12.1 Global Nuclear Medicine/Radiopharmaceutic Capacity, Production, Revenue Forecast (2019-2024)
12.1.1 Global Nuclear Medicine/Radiopharmaceutic Capacity, Production and Growth Rate Forecast (2019-2024)
12.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate Forecast (2019-2024)
12.1.3 Global Nuclear Medicine/Radiopharmaceutic Price and Trend Forecast (2019-2024)
12.2 Global Nuclear Medicine/Radiopharmaceutic Production, Consumption , Import and Export Forecast by Region (2019-2024)
12.2.1 North America Nuclear Medicine/Radiopharmaceutic Production, Revenue, Consumption, Export and Import Forecast (2019-2024)
12.2.2 Europe Nuclear Medicine/Radiopharmaceutic Production, Revenue, Consumption, Export and Import Forecast (2019-2024)
12.2.3 China Nuclear Medicine/Radiopharmaceutic Production, Revenue, Consumption, Export and Import Forecast (2019-2024)
12.2.4 Japan Nuclear Medicine/Radiopharmaceutic Production, Revenue, Consumption, Export and Import Forecast (2019-2024)
12.2.5 Southeast Asia Nuclear Medicine/Radiopharmaceutic Production, Revenue, Consumption, Export and Import Forecast (2019-2024)
12.2.6 India Nuclear Medicine/Radiopharmaceutic Production, Revenue, Consumption, Export and Import Forecast (2019-2024)
12.3 Global Nuclear Medicine/Radiopharmaceutic Production, Revenue and Price Forecast by Type (2019-2024)
12.4 Global Nuclear Medicine/Radiopharmaceutic Consumption Forecast by Application (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
